Medical treatment of ectopic pregnancy: a committee opinion
Appropriate use of medical therapy of early ectopic pregnancies is discussed.
Authors
The Practice Committee of the American Society for Reproductive Medicine
Volume 100, Issue 3, Pages 638-644, September 2013
Abstract
Methotrexate, a folic acid antagonist, is an effective treatment for early unruptured ectopic pregnancy. Several treatment regimens are available. Methotrexate is more effective when used to treat ectopic pregnancies with lower human chorionic gonadotropin (hCG) levels. However, there is no consensus on a threshold value that best predicts success or failure. Methotrexate can be used to treat ectopic pregnancies that occur in cornual, cervical, and cesarean scar locations and does not adversely affect ovarian reserve or subsequent fertility. This document replaces the previous document of the same name, last published in 2008 (Fertil Steril 2008;90:S206–12.0).
Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00707-3/fulltext
